⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Diosgenin
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-01 — Diosgenin Alleviates Age-Related Sarcopenia by Promoting Satellite Cell Proliferation and Myogenic Differentiation via Activation of the SIRT1/PGC-1α Signaling Pathway.: Aged-mouse plus D-gal-senescent C2C12 study: diosgenin improved grip strength, endurance, muscle mass and CSA, and restored satellite-cell proliferation/myogenic differentiation via direct SIRT1 binding and PGC-1α deacetylation, with effects abolished by the SIRT1 inhibitor EX527. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Diosgenin Alleviates Age-Related Sarcopenia by Promoting Satellite Cell Proliferation and Myogenic Differentiation via Activation of the SIRT1/PGC-1α Signaling Pathway.
01-aug-2026
novelty 3
per-area 3
strengthens